These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

107 related articles for article (PubMed ID: 7387773)

  • 1. Comparative evaluation of some pharmacological properties and side effects of D-glucitol hexanicotinate (sorbinicate) and nicotinic acid correlated with the plasma concentration of nicotinic acid.
    Subissi A; Schiantarelli P; Biagi M; Sardelli G
    Atherosclerosis; 1980 May; 36(1):135-48. PubMed ID: 7387773
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Correlation between the plasma concentration of free nicotinic acid and some of its pharmacological effects in the fasted rat after an oral dose of sorbinicate and of nicotinic acid.
    Subissi A; Murmann W
    Arzneimittelforschung; 1978; 28(7):1143-5. PubMed ID: 582703
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Some aspects of sorbinicate pharmacokinetics.
    Subissi A; Biagi M; Murmann W
    Arzneimittelforschung; 1980; 30(8):1278-84. PubMed ID: 7192142
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Acute effects on plasma lipids in the rat of a new long-acting nicotinic acid derivative: LG 13979.
    Subissi A; Criscuoli M; Biagi M; Murmann W
    J Pharm Pharmacol; 1983 Sep; 35(9):571-5. PubMed ID: 6138406
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Effect of sorbinicate (nicotinic hexaester of D-glucitol) on the plasma FFA; plasma levels of nicotinic acid after sorbinicate administration.
    Avogaro P; Bittolo-Bon G; Cazzolato G
    Pharmacol Res Commun; 1978 Feb; 10(2):127-31. PubMed ID: 349572
    [No Abstract]   [Full Text] [Related]  

  • 6. Effects of experimental atherosclerosis on cerebral blood flow in rabbits. Reversal by sorbinicate.
    Lanza E; Dionigi R; Subissi A; Piccinini F
    Artery; 1982; 11(1):64-73. PubMed ID: 7171322
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Effect of D-glucitol-hexanicotinate on platelet aggregability in patients with coronary heart disease.
    Sommariva D; Panigo FE; Rovelli L; Bonfiglioli D; Garimoldi M; Cialfi A; Gandini R; Fasoli A
    Int J Clin Pharmacol Ther Toxicol; 1984 May; 22(5):265-8. PubMed ID: 6746150
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Possible glucagon-mediated hypocholesterolemic activity of a nicotinic acid derivative (sorbinicate).
    Uccella R; Morenghi R; Agosti C; Saponati G
    Artery; 1983; 11(5):400-12. PubMed ID: 6661043
    [TBL] [Abstract][Full Text] [Related]  

  • 9. [Pharmacokinetics and antilipolytic effect of a derivative of nicotinic acid (sorbinicate) in dialyzed uremic patients].
    Zuliani U; Bonetti A; Orlandini G; Manari A; David S; Garini G
    Farmaco Prat; 1981 Sep; 36(9):416-23. PubMed ID: 7308427
    [No Abstract]   [Full Text] [Related]  

  • 10. On the absorption, distribution and excretion of sorbinicate in the rat and the monkey.
    Giachetti C; Mondino A; Silvestri S; Zanolo G; Bramanti G; Criscuoli M; Subissi A
    Arzneimittelforschung; 1982; 32(11):1433-6. PubMed ID: 6891249
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Effects of sorbinicate and nicotinic acid on blood viscosity, red cell deformation and platelet function.
    Strano A; Novo S; Davì G; Avellone G; Mandalà V
    Pharmacol Res Commun; 1982 Jul; 14(7):639-48. PubMed ID: 7134249
    [No Abstract]   [Full Text] [Related]  

  • 12. [Activation of fibrinolysis after oral administration of D-glucitol-hexanicotinate. Preliminary data].
    Pinto A; Novo S; Avellone G; Vinci G
    Boll Soc Ital Cardiol; 1978; 23(4):641-5. PubMed ID: 757348
    [No Abstract]   [Full Text] [Related]  

  • 13. [D-glucitol hexanicotinate and platelet aggregation].
    Avellone G; Novo S; Mandalà V
    Farmaco Prat; 1980 Mar; 35(3):147-54. PubMed ID: 7439355
    [No Abstract]   [Full Text] [Related]  

  • 14. [Activation of fibrinolysis induced by D-glucitol-hexanicotinate].
    Novo S; Avellone G; Pinto A; Fazio M
    Farmaco Prat; 1980 Mar; 35(3):155-60. PubMed ID: 7439356
    [No Abstract]   [Full Text] [Related]  

  • 15. Actions of vitamins A and E and some nicotinic acid derivatives on plasma lipids and on lipid infiltration of aorta in cholesterol-fed rabbits.
    Brattsand R
    Atherosclerosis; 1975; 22(1):47-61. PubMed ID: 1156470
    [TBL] [Abstract][Full Text] [Related]  

  • 16. [Effect of sorbinicate on blood proteins and platelet aggregation in patients with coronary disease].
    Bonfiglioli D; Sommariva D; Rovelli L; Panigo F; Gatti P; Cialfi A; Grimoldi M; Cabrini E; Fasoli A
    Clin Ter; 1984 Jul; 110(2):111-8. PubMed ID: 6237851
    [No Abstract]   [Full Text] [Related]  

  • 17. Action of niceritrol (pentaerythritoltetranicotinate) on lipid accumulation in aortas of cholesterol-fed rabbits independent of contemporary reduction of serum lipids.
    Brattsand R; Petersen H; Lundholm L
    Atherosclerosis; 1974; 20(3):469-79. PubMed ID: 4373018
    [No Abstract]   [Full Text] [Related]  

  • 18. Metabolic changes induced by a nicotinic acid derivative in patients with obesity grades 1, 2 and 3.
    Santagostino A; Pagani G; Ballerio G; Porro T
    Panminerva Med; 1979; 21(3):111-26. PubMed ID: 554045
    [No Abstract]   [Full Text] [Related]  

  • 19. [A polyalcohol derivative with hypocholesterolemic and hypolipemic properties: sorbitol hexanicotinate].
    DELL'OMODARME G; BRUNORI F
    Boll Chim Farm; 1961 Oct; 100():732-44. PubMed ID: 13885164
    [No Abstract]   [Full Text] [Related]  

  • 20. The effect of niceritrol (pentaerythritoltetranicotinate) and clofibrate upon hyperlipemia and atherosclerosis induced in rabbits by cholesterol-free semisynthetic diets.
    Brattsand R
    Atherosclerosis; 1974; 20(3):453-67. PubMed ID: 4373017
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 6.